{"name":"Terumo","slug":"terumo","ticker":"4543","exchange":"TSE","domain":"terumo.com","description":"Terumo Corporation  was founded in 1921 as Red Line Thermometer Corporation by a group of medical scientists led by Dr. Kitasato Shibasaburō to produce medical thermometers in Japan.","hq":"Tokyo, Japan","founded":1950,"employees":"~75,000","ceo":"Hikaru Samejima","sector":"Blood Management / Vascular / Cardiac Surgery","stockPrice":1930,"stockChange":-20,"stockChangePercent":-1.03,"marketCap":"$18.0B","metrics":{"revenue":6926223324.469382,"revenueGrowth":12.6,"grossMargin":53.3,"rdSpend":0,"netIncome":808663050.1675221,"cash":1504735536.1180549,"dividendYield":1.54,"peRatio":21.8,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Seldane patent cliff ($0.0B at risk)","drug":"Seldane","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"earnings","headline":"Terumo Reports Fiscal 2023 Earnings","summary":"Terumo Corporation announced its fiscal 2023 earnings, with revenue increasing by 5.6% year-over-year.","drugName":"","sentiment":"neutral"},{"date":"2023-09-01","type":"deal","headline":"Terumo Acquires US-Based Medical Device Company","summary":"Terumo Corporation acquired a US-based medical device company to expand its presence in the North American market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE9IZGZXemlxMW9PV3hoblhQT00wVnFjY29LUHBYMUVqQ2xWd0t2dTJtTThzRmJrSi0zVWpvOUFTbUx1bkN1VEJRMktDMmtPMnV3SUFGZA?oc=5","date":"2026-04-02","type":"pipeline","source":"Yahoo Finance Australia","summary":"Terumo Corporation (4543.T) stock price, news, quote and history - Yahoo Finance Australia","headline":"Terumo Corporation (4543.T) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQa2RYQUNYYnJjVFR5T3lrbFJiZHhrOHgxVkliVVNOcmE3T2daYmkyQkh2UVFGczE3cXNqdWhDS054THNqdE5RbUN5aE5PNmVESlh3UUJiUzVSaVltcy1KMXZLSVk5QVFSTHdaUjhNaWdTVW9yRWYwR181YUlLbGdOLWtCUzgyN2tWN2VLRmYweE5FbUV4amZrc3lLV2RhbEpxUTVET3BmSFFWVDQ?oc=5","date":"2024-07-30","type":"pipeline","source":"businesswireindia.com","summary":"Terumo India Wins Big for Its Health & Wellbeing Initiatives - businesswireindia.com","headline":"Terumo India Wins Big for Its Health & Wellbeing Initiatives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUVhJR2xRb2ZSSXpRT0dJNWhOcEhBSDU5U2hMVGlvdFhFdjNfTXVQOVFSR2VORjJkNW1qYWNsUm5qcGhaVU4tengzRU9GMG52NzRfd0pkSV8tS1pMSHU1anVhOGg0Y1F3N04weXdweXRxdEdWWDFWYm1FR2FNaHIwVWtkLUJhSGFSWDF0dURxNFVXbjF0QUx6TkE3UVo1VTFzeGYyZHlhTXhNV052Z3o4bGNPQlJWc25neFV3NTBka3l6T3UyaE9meDA5SU9DVndNVmQ5QVBR?oc=5","date":"2023-12-18","type":"pipeline","source":"businesswireindia.com","summary":"Terumo India Advances Treatment Options for Heart Disease with the Launch of Ultimaster Nagomi - businesswireindia.com","headline":"Terumo India Advances Treatment Options for Heart Disease with the Launch of Ultimaster Nagomi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNSGdjenQ2SFRYSW81c3RQUGVrZGhFSnZ6UnlUYjZsbFhacGxCNHBuSHpoNGRmOGMtcUk2TmhNdVNuVDUyOEt2WHh4RVVzUWpGODktR0tMLTZ5aV9nVzNjUW8zX2NXaFNsOWlCZUt2QWxIMFBuaUt4NC1qa1puSVlCdjVILUhVYmJZdnRReV9xUzRVSWVXVzhHY09XZURvYm94WUxaUDhmcUxJdTNqam1udHVpb2pjQW1IZ2RPNXloOUtnTmVl?oc=5","date":"2022-05-23","type":"trial","source":"BioPharma APAC","summary":"Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing - BioPharma APAC","headline":"Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNWExlMlJucHp3LXJSTHpzVWlOVHQ3NjVHYU9HZnVDVldGaklHSWlpaThhZjRPeWFHRFRPS1diZmxsM3ZhQ3NsMXFqUzdXWXJkQmkyU1EtcE41U09IWnlwLUNCSVFvc25kQ19Iai1RdWJVZTJIZ2ZIRVlfcGlVd3hNeHFaV1JyRVYzRFZuNHBEU1JTUWNSNVVOTVJ3aXdwSXdOUUpZMjlEYm1HeGpCNWpQQkZPLVZaRjVsYlRxU0o5WGxJaHpPUDNuS3MzemFVZGdKV2RIMXBmUWZlbTRqcXhPQklJQmpuZUFYSkh5eEliVTMzelY1aTZPMFcwUFU?oc=5","date":"2021-02-07","type":"trial","source":"Newswire Canada","summary":"A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan - Newswire Canada","headline":"A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan","sentiment":"neutral"}],"patents":[{"drugName":"Seldane","drugSlug":"terfenadine","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Becton Dickinson","B. Braun Melsungen","Medtronic"],"therapeuticFocus":["Blood Management","Vascular","Cardiac Surgery"],"financials":{"source":"yahoo_finance","revenue":6551161513.009399,"revenuePeriod":"2025-03-31","revenueHistory":[{"period":"2025-03-31","value":6551161513.009399},{"period":"2024-03-31","value":5828452452.2182},{"period":"2023-03-31","value":5185747944.5226},{"period":"2022-03-31","value":4446613103.0342}],"grossProfit":3544820039.838,"grossProfitHistory":[{"period":"2025-03-31","value":3544820039.838},{"period":"2024-03-31","value":3029563910.6236},{"period":"2023-03-31","value":2638803565.7465997},{"period":"2022-03-31","value":2335147909.3473997}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":2412958564.8672,"operatingIncome":996864065.638,"operatingIncomeHistory":[{"period":"2025-03-31","value":996864065.638},{"period":"2024-03-31","value":885746630.783},{"period":"2023-03-31","value":741834536.7761999},{"period":"2022-03-31","value":733153783.544}],"netIncome":739590059.4291999,"netIncomeHistory":[{"period":"2025-03-31","value":739590059.4291999},{"period":"2024-03-31","value":672546572.7035999},{"period":"2023-03-31","value":564754757.805},{"period":"2022-03-31","value":561517652.4482}],"eps":78.99,"epsHistory":[{"period":"2025-03-31","value":78.99},{"period":"2024-03-31","value":71.47},{"period":"2023-03-31","value":59.48},{"period":"2022-03-31","value":58.69}],"cash":1402779374.4608,"cashHistory":[{"period":"2025-03-31","value":1402779374.4608},{"period":"2024-03-31","value":1295366907.8462},{"period":"2023-03-31","value":1184337987.5908},{"period":"2022-03-31","value":1297693577.3214}],"totalAssets":11559962450.4602,"totalLiabilities":2907439053.0611997,"totalDebt":1105408254.6332,"equity":8652523397.399,"operatingCashflow":1332789616.0628,"operatingCashflowHistory":[{"period":"2025-03-31","value":1332789616.0628},{"period":"2024-03-31","value":925167239.962},{"period":"2023-03-31","value":743117998.4704},{"period":"2022-03-31","value":894421061.5438}],"capex":-520750356.861,"capexHistory":[{"period":"2025-03-31","value":-520750356.861},{"period":"2024-03-31","value":-498046362.0636},{"period":"2023-03-31","value":-456311728.3522},{"period":"2022-03-31","value":-468526743.097}],"freeCashflow":812039259.2018,"dividendsPaid":-225219076.2108,"buybacks":-189996588.0414,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1930,"previousClose":1950,"fiftyTwoWeekHigh":2818,"fiftyTwoWeekLow":1900,"fiftyTwoWeekRange":"1900.0 - 2818.0","fiftyDayAverage":2078.91,"twoHundredDayAverage":2315.66,"beta":0.18,"enterpriseValue":19331432161.606003,"forwardPE":19,"priceToBook":1.87,"priceToSales":2.6,"enterpriseToRevenue":2.79,"enterpriseToEbitda":11.7,"pegRatio":0,"ebitda":1652599154.1133082,"ebitdaMargin":23.9,"freeCashflow":457170018.9175218,"operatingCashflow":1318039291.5005145,"totalDebt":2836791752.781942,"debtToEquity":29.5,"currentRatio":1.51,"returnOnAssets":5.9,"returnOnEquity":8.7,"analystRating":"1.6 - Buy","recommendationKey":"buy","numberOfAnalysts":13,"targetMeanPrice":2867.69,"targetHighPrice":3700,"targetLowPrice":2100,"dividendRate":30,"payoutRatio":0.32,"fiveYearAvgDividendYield":0.91,"exDividendDate":1774828800,"insiderHeldPercent":2.6,"institutionHeldPercent":61.7,"sharesOutstanding":1475072090,"floatShares":1445260883,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":88.53,"epsForward":101.83,"revenuePerShare":742.71,"bookValue":1032.04,"officers":[{"age":67,"name":"Mr. Toshiaki  Takagi","title":"Chairman of the Board & Group Managing Executive Officer"},{"age":61,"name":"Mr. Hikaru  Samejima","title":"Representative Director, President & CEO"},{"age":null,"name":"Jin  Hagimoto","title":"CFO, CIO, GM of Accounting, Corporate Planning, Tax, IT Planning Dept. & GBS"},{"age":null,"name":"Shinji  Omori Ph.D.","title":"CTO, Corporate R&D Officer, GM of R&D Center & Executive Officer"},{"age":null,"name":"Ms. Miho  Mizuguchi","title":"Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department"},{"age":null,"name":"Tomoko  Adachi","title":"Chief Human Resources Officer & Group Executive Officer"},{"age":null,"name":"Itaru  Sakaguchi","title":"Group Managing Executive Officer"},{"age":null,"name":"Fumihisa  Hirose","title":"Group Managing Executive Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://www.terumo.com/investor/index.html","website":"https://www.terumo.com","phone":"81 3 3374 8111"}}